Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit ...

Nitrous oxide may offer quick, short-term relief for people with major depression, especially those who haven’t responded to ...

The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy ...

Nitrous oxide, better known as laughing gas, is quietly emerging as one of the most intriguing rapid-acting options for ...

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

The team behind the research are now preparing the first UK National Health Service trial to test whether nitrous oxide can be used safely and effectively as a real-world treatment.

The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates, including KOR ...

Laughing gas (nitrous oxide) appears to offer rapid mood improvement for people with severe or treatment-resistant depression ...

Also known as seasonal depression, it is largely characterized by recurring, seasonal episodes of depression that follow a ...

Nitrous oxide, better known as laughing gas, is emerging from the dental chair and operating room as one of the most ...

A systematic review and meta-analysis in eBioMedicine shows that nitrous oxide can rapidly reduce depressive symptoms within ...

The FL-100 tDCS system is available by prescription for adults with moderate to severe MDD in the current episode, either as monotherapy or as an adjunctive treatment.